Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced β5-integrin expression in human gastric cancer SC-M1 cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 7, 2012, Pages 1102-1110

  Hung, Wen Yi ^a   Huang, Kuo Hung ^a,b   Wu, Chew Wun ^a,b   Chi, Chin Wen ^a,b   Kao, Hwa Li ^b   Li, Anna Fen Yau ^b   Yin, Pen Hui ^b   Lee, Hsin Chen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

5 Integrin; Gastric cancer; Migration; Mitochondrial dysfunction; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; BETA5 INTEGRIN; NEUTRALIZING ANTIBODY; OLIGOMYCIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL MIGRATION; CELL SUBPOPULATION; CELL SURFACE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TRANSWELL ASSAY; UPREGULATION;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; ANTIMYCIN A; BLOTTING, WESTERN; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; FREE RADICAL SCAVENGERS; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN BETA CHAINS; MITOCHONDRIA; NEOPLASM INVASIVENESS; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VITRONECTIN;

EID: 84860803392     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.04.016     Document Type: Article

References (47)

1. A.J. Kowaltowski, N.C. de Souza-Pinto, R.F. Castilho, and A.E. Vercesi Mitochondria and reactive oxygen species Free Radic. Biol. Med. 47 2009 333 343
2. M.P. Murphy How mitochondria produce reactive oxygen species Biochem. J. 417 2009 1 13
3. A. Chatterjee, E. Mambo, and D. Sidransky Mitochondrial DNA mutations in human cancer Oncogene 25 2006 4663 4674
4. H.C. Lee, and Y.H. Wei Mitochondrial DNA instability and metabolic shift in human cancers Int. J. Mol. Sci. 10 2009 674 701
5. H.C. Lee, C.M. Chang, and C.W. Chi Somatic mutations of mitochondrial DNA in aging and cancer progression Ageing Res. Rev. 9 2010 S47 S58
6. A. Tamori, S. Nishiguchi, M. Nishikawa, S. Kubo, N. Koh, K. Hirohashi, S. Shiomi, and M. Inoue Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma J. Gastroenterol. 39 2004 1063 1068
7. A. Lievre, C. Chapusot, A.M. Bouvier, F. Zinzindohoue, F. Piard, P. Roignot, L. Arnould, P. Beaune, J. Faivre, and P. Laurent-Puig Clinical value of mitochondrial mutations in colorectal cancer J. Clin. Oncol. 23 2005 3517 3525
8. W. Matsuyama, M. Nakagawa, J. Wakimoto, Y. Hirotsu, M. Kawabata, and M. Osame Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer Hum. Mutat. 21 2003 441 443
9. L.M. Tseng, P.H. Yin, C.W. Chi, C.Y. Hsu, C.W. Wu, L.M. Lee, Y.H. Wei, and H.C. Lee Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer Genes Chromosomes Cancer 45 2006 629 638
10. H. Simonnet, N. Alazard, K. Pfeiffer, C. Gallou, C. Beroud, J. Demont, R. Bouvier, H. Schagger, and C. Godinot Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma Carcinogenesis 23 2002 759 768
11. L.J. Burgart, J. Zheng, Q. Shu, J.G. Strickler, and D. Shibata Somatic mitochondrial mutation in gastric cancer Am. J. Pathol. 147 1995 1105 1111
12. V. Maximo, P. Soares, R. Seruca, A.S. Rocha, P. Castro, and M. Sobrinho-Simoes Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma Genes Chromosomes Cancer 32 2001 136 143
13. C.W. Wu, P.H. Yin, W.Y. Hung, A.F.Y. Li, S.H. Li, C.W. Chi, Y.H. Wei, and H.C. Lee Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer Genes Chromosomes Cancer 44 2005 19 28
14. W.Y. Hung, C.W. Wu, P.H. Yin, C.J. Chang, A.F. Li, C.W. Chi, Y.H. Wei, and H.C. Lee Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer Biochim. Biophys. Acta 1800 2010 264 270
15. A. Isidoro, M. Martinez, P.L. Fernandez, A.D. Ortega, G. Santamaria, M. Chamorro, J.C. Reed, and J.M. Cuezva Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer Biochem. J. 378 2004 17 20
16. W.S. Wu The signaling mechanism of ROS in tumor progression Cancer Metastasis Rev. 25 2006 695 705
17. C.C. Tzeng, C.L. Meng, L. Jin, and H.F. Hsieh Cytogenetic studies of gastric adenocarcinoma Cancer Genet. Cytogenet. 55 1991 67 71
18. H.C. Lee, P.H. Yin, C.Y. Lu, C.W. Chi, and Y.H. Wei Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells Biochem. J. 348 Pt 2 2000 425 432
19. K.M. Robinson, M.S. Janes, and J.S. Beckman The selective detection of mitochondrial superoxide by live cell imaging Nat. Protoc. 3 2008 941 947
20. C.W. Wu, J.H. Chen, H.L. Kao, A.F.Y. Li, C.H. Lai, C.W. Chi, and W.C. Lin PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma Anticancer Res. 26 2006 1643 1649
21. G. Poli, G. Leonarduzzi, F. Biasi, and E. Chiarpotto Oxidative stress and cell signalling Curr. Med. Chem. 11 2004 1163 1182
22. 2, a necessary evil for cell signaling Science 312 2006 1882 1883
23. G. Lenaz, A. Baracca, V. Carelli, M. D'Aurelio, G. Sgarbi, and G. Solaini Bioenergetics of mitochondrial diseases associated with mtDNA mutations Biochim. Biophys. Acta 1658 2004 89 94
24. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Annu. Rev. Genet. 39 2005 359 407
25. M. Brandon, P. Baldi, and D.C. Wallace Mitochondrial mutations in cancer Oncogene 25 2006 4647 4662
26. G. Pani, T. Galeotti, and P. Chiarugi Metastasis: cancer cell's escape from oxidative stress Cancer Metastasis Rev. 29 2010 351 378
27. Y. Shidara, K. Yamagata, T. Kanamori, K. Nakano, J.Q. Kwong, G. Manfredi, H. Oda, and S. Ohta Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis Cancer Res. 65 2005 1655 1663
28. E. Bonora, A.M. Porcelli, G. Gasparre, A. Biondi, A. Ghelli, V. Carelli, A. Baracca, G. Tallini, A. Martinuzzi, G. Lenaz, M. Rugolo, and G. Romeo Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III Cancer Res. 66 2006 6087 6096
29. A. Baracca, G. Sgarbi, M. Mattiazzi, G. Casalena, E. Pagnotta, M.L. Valentino, M. Moggio, G. Lenaz, V. Carelli, and G. Solaini Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993 Biochim. Biophys. Acta 1767 2007 913 919
30. K. Ishikawa, K. Takenaga, M. Akimoto, N. Koshikawa, A. Yamaguchi, H. Imanishi, K. Nakada, Y. Honma, and J.I. Hayashi ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis Science 320 2008 661 664
31. J.S. Park, L.K. Sharma, H. Li, R. Xiang, D. Holstein, J. Wu, J. Lechleiter, S.L. Naylor, J.J. Deng, J. Lu, and Y. Bai A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis Hum. Mol. Genet. 18 2009 1578 1589
32. S. Hehlgans, M. Haase, and N. Cordes Signaling via integrins: implications for cell survival and anticancer strategies Biochim. Biophys. Acta 1775 2007 163 180
33. S. Huveneers, H. Truong, and E.H.J. Danen Integrins: signaling, disease, and therapy Int. J. Radiat. Biol. 83 2007 743 751
34. A. van der Flier, and A. Sonnenberg Function and interactions of integrins Cell Tissue Res. 305 2001 285 298
35. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, and D.A. Cheresh Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3 Cell 85 1996 683 693
36. L.M. Shaw, I. Rabinovitz, H.H.F. Wang, A. Toker, and A.M. Mercurio Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion Cell 91 1997 949 960
37. N. Zahir, J.N. Lakins, A. Russell, W. Ming, C. Chatterjee, G.I. Rozenberg, M.P. Marinkovich, and V.M. Weaver Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors J. Cell Biol. 163 2003 1397 1407
38. S. Kim, M. Harris, and J.A. Varner Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A J. Biol. Chem. 275 2000 33920 33928
39. S. Kim, K. Bell, S.A. Mousa, and J.A. Varner Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin Am. J. Pathol. 156 2000 1345 1362
40. Y. Saito, W. Sekine, R. Sano, S. Komatsu, H. Mizuno, K. Katabami, K. Shimada, T. Oku, and T. Tsuji Potentiation of cell invasion and matrix metalloproteinase production by α3β1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5 Clin. Exp. Metastasis 27 2010 197 205
41. R. Zhao, X.Q. Liu, X.P. Wu, Y.F. Liu, Z.Y. Zhang, G.Y. Yang, S. Guo, J. Niu, J.Y. Wang, and K.S. Xu Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin αvβ6 Cancer Lett. 287 2010 150 156
42. E. Kawahara, A. Ooi, and I. Nakanishi Integrin distribution in gastric carcinoma: association of β3 and β5 integrins with tumor invasiveness Pathol. Int. 45 1995 493 500
43. M. Lehmann, C. Rabenandrasana, R. Tamura, J.C. Lissitzky, V. Quaranta, J. Pichon, and J. Marvaldi A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins αvβ3, αvβ5, and αvβ6 Cancer Res. 54 1994 2102 2107
44. B.P. Eliceiri, R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability Mol. Cell 4 1999 915 924
45. J.M. Ricono, M. Huang, L.A. Barnes, S.K. Lau, S.M. Weis, D.D. Schlaepfer, S.K. Hanks, and D.A. Cheresh Specific cross-talk between epidermal growth factor receptor and integrin αvβ5 promotes carcinoma cell invasion and metastasis Cancer Res. 69 2009 1383 1391
46. A. Bianchi, M.E. Gervasi, and A. Bakin Role of β5-integrin in epithelial-mesenchymal transition in response to TGF-β Cell Cycle 9 2010 1647 1659
47. S.Y. Ahn, Y.S. Choi, H.J. Koo, J.H. Jeong, W.H. Park, M. Kim, Y. Piao, and Y.K. Pak Mitochondrial dysfunction enhances the migration of vascular smooth muscle cells via suppression of Akt phosphorylation Biochim. Biophys. Acta 1800 2010 275 281